186 related articles for article (PubMed ID: 32988968)
1. Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation.
Maitland ML; Wilkerson J; Karovic S; Zhao B; Flynn J; Zhou M; Hilden P; Ahmed FS; Dercle L; Moskowitz CS; Tang Y; Connors DE; Adam SJ; Kelloff G; Gonen M; Fojo T; Schwartz LH; Oxnard GR
Clin Cancer Res; 2020 Dec; 26(24):6464-6474. PubMed ID: 32988968
[TBL] [Abstract][Full Text] [Related]
2. Volumetric Versus Unidimensional Measures of Metastatic Colorectal Cancer in Assessing Disease Response.
Lubner MG; Stabo N; Lubner SJ; Del Rio AM; Song C; Pickhardt PJ
Clin Colorectal Cancer; 2017 Dec; 16(4):324-333.e1. PubMed ID: 28433601
[TBL] [Abstract][Full Text] [Related]
3. Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.
Hayes SA; Pietanza MC; O'Driscoll D; Zheng J; Moskowitz CS; Kris MG; Ginsberg MS
Eur J Radiol; 2016 Mar; 85(3):524-33. PubMed ID: 26860663
[TBL] [Abstract][Full Text] [Related]
4. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.
Prasad SR; Jhaveri KS; Saini S; Hahn PF; Halpern EF; Sumner JE
Radiology; 2002 Nov; 225(2):416-9. PubMed ID: 12409574
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer.
Huellner MW; Hennedige TP; Winterhalder R; Zander T; Venkatesh SK; Yong WP; Soo RA; Seifert B; Treumann TC; Strobel K; Veit-Haibach P
Cancer Imaging; 2012 May; 12(1):212-24. PubMed ID: 22750105
[TBL] [Abstract][Full Text] [Related]
6. CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
Owen B; Gandara D; Kelly K; Moore E; Shelton D; Knollmann F
Clin Lung Cancer; 2020 May; 21(3):225-231. PubMed ID: 31699509
[TBL] [Abstract][Full Text] [Related]
7. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST.
Fang WJ; Lam KO; Ng SC; Choi CW; Kwong DL; Zheng SS; Lee VH
Asian Pac J Cancer Prev; 2013; 14(7):4151-5. PubMed ID: 23991968
[TBL] [Abstract][Full Text] [Related]
8. Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study.
Hosokawa A; Yamazaki K; Matsuda C; Ueda S; Kusaba H; Okamura S; Tsuda M; Tamura T; Shinozaki K; Tsushima T; Tsuda T; Shirakawa T; Yamashita H; Morita S; Hironaka S; Muro K
Medicine (Baltimore); 2020 Sep; 99(36):e22060. PubMed ID: 32899071
[TBL] [Abstract][Full Text] [Related]
9. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
10. MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
Siu HWD; Tebbutt N; Chantrill L; Karapetis C; Steer C; Wilson K; Espinoza D; Bailey L; Yip S; Cuff J; Pavlakis N; Thavaneswaran S; Briscoe K; Srivastav R; Shannon J; Segelov E; Tie J; Caird S; Francesconi A; Price T; Wuttke M; Ladwa R; Sjoquist K; Burge M
BMC Cancer; 2021 Aug; 21(1):932. PubMed ID: 34407800
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab.
Ricotta R; Vanzulli A; Moroni M; Colnago B; Oriani M; Nichelatti M; Sarnataro C; Venturini F; Di Bella S; Maiolani M; Giganti MO; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2013 Mar; 12(1):45-53. PubMed ID: 23041354
[TBL] [Abstract][Full Text] [Related]
12. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.
Dercle L; Lu L; Schwartz LH; Qian M; Tejpar S; Eggleton P; Zhao B; Piessevaux H
J Natl Cancer Inst; 2020 Sep; 112(9):902-912. PubMed ID: 32016387
[TBL] [Abstract][Full Text] [Related]
13. Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomography.
Knollmann FD; Kumthekar R; Fetzer D; Socinski MA
Clin Lung Cancer; 2014 Mar; 15(2):103-9. PubMed ID: 24361250
[TBL] [Abstract][Full Text] [Related]
14. Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
Winter KS; Hofmann FO; Thierfelder KM; Holch JW; Hesse N; Baumann AB; Modest DP; Stintzing S; Heinemann V; Ricke J; Sommer WH; D'Anastasi M
Eur Radiol; 2018 Nov; 28(11):4839-4848. PubMed ID: 29736851
[TBL] [Abstract][Full Text] [Related]
15. Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies.
Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
Clin Colorectal Cancer; 2018 Sep; 17(3):170-178.e3. PubMed ID: 29627309
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.
Tran LN; Brown MS; Goldin JG; Yan X; Pais RC; McNitt-Gray MF; Gjertson D; Rogers SR; Aberle DR
Acad Radiol; 2004 Dec; 11(12):1355-60. PubMed ID: 15596373
[TBL] [Abstract][Full Text] [Related]
17. Comparing RECIST with EORTC criteria in metastatic bladder cancer.
Öztürk H
J Cancer Res Clin Oncol; 2016 Jan; 142(1):187-94. PubMed ID: 26208817
[TBL] [Abstract][Full Text] [Related]
18. An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans.
Dercle L; Zhao B; Gönen M; Moskowitz CS; Connors DE; Yang H; Lu L; Reidy-Lagunes D; Fojo T; Karovic S; Maitland ML; Oxnard GR; Schwartz LH
Eur J Cancer; 2022 Jan; 161():138-147. PubMed ID: 34916122
[TBL] [Abstract][Full Text] [Related]
19. Comparison of RECIST 1.0 and RECIST 1.1 on computed tomography in patients with metastatic colorectal cancer.
Jang HJ; Kim BC; Kim HS; Kim JH; Song HH; Kim JB; Park JJ; Yoon SN; Woo JY; Zang DY
Oncology; 2014; 86(2):117-21. PubMed ID: 24480800
[TBL] [Abstract][Full Text] [Related]
20. Volumetric evaluation of therapy response in patients with lung metastases. Preliminary results with a computer system (CAD) and comparison with unidimensional measurements.
Fraioli F; Bertoletti L; Napoli A; Calabrese FA; Masciangelo R; Cortesi E; Catalano C; Passariello R
Radiol Med; 2006 Apr; 111(3):365-75. PubMed ID: 16683084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
